Sudeep Pharma Ltd

Sudeep Pharma Ltd, a player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 7 September 2026, as its stock price soared to an all-time high of Rs.1376. This marks a remarkable phase in the company’s market journey, reflecting sustained gains and robust performance metrics over recent months.

Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 September 2026, providing investors with the latest insights into its performance and outlook.

With a decisive surge to Rs 1329.95 on 4 Sep 2026, Sudeep Pharma Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of robust technical indicators and sustained price momentum over the past eight trading sessions.

Extending its winning streak to eight consecutive sessions, Sudeep Pharma Ltd surged to a fresh all-time high of Rs 1,325.7 on 4 Sep 2026, outpacing its sector and the broader market by a wide margin.

Extending a remarkable seven-day winning streak, Sudeep Pharma Ltd surged to a fresh all-time high of Rs 1,292 on 3 Sep 2026, outpacing its sector and the broader market with a 4.88% gain on the day.

With a decisive surge to Rs 1284.95 on 3 Sep 2026, Sudeep Pharma Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of strong technical signals and sustained price momentum over the past week.

At Rs 1,292.40, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Sudeep Pharma Ltd locked at its upper circuit of 5% on 2 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Surging past its previous peaks, Sudeep Pharma Ltd touched a new 52-week high of Rs 1274.85 on 2 Sep 2026, marking a significant milestone in its price journey. This breakout comes amid a six-day winning streak that has propelled the stock up by 12.38%, outpacing its sector and the broader market despite a bearish Sensex backdrop.

Extending its winning streak to six consecutive sessions, Sudeep Pharma Ltd surged 3.81% on 2 Sep 2026 to close at Rs 1,270.35, marking a fresh all-time high. This rally comes amid a broader outperformance against the Sensex, which declined 0.73% on the same day, underscoring the stock’s robust momentum across multiple timeframes.

After a steady five-day ascent delivering over 10.6% returns, Sudeep Pharma Ltd surged to a fresh 52-week and all-time high of Rs 1264.25 on 1 Sep 2026, outpacing its sector by 3.71% despite a broader market retreat. This milestone caps a remarkable journey from its 52-week low of Rs 524.95, underscoring the stock’s robust price momentum and technical alignment.

After a modest gap down at the open, Sudeep Pharma Ltd staged a strong recovery to close at a fresh all-time high of Rs 1,257.25 on 1 Sep 2026, extending its winning streak to five consecutive sessions with a cumulative gain of 10.88% during this period.

At Rs 1209.7, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Sudeep Pharma Ltd locked at its upper circuit of 5.0% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares.

With a decisive surge to Rs 1207.75 on 31 Aug 2026, Sudeep Pharma Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum despite a broadly weakening market backdrop.

Extending its winning streak to four sessions, Sudeep Pharma Ltd surged 3.32% on 31 Aug 2026 to close at Rs 1,191, just 0.14% above its 52-week high. This rally comes amid strong outperformance against the Sensex and sector benchmarks, signalling robust momentum across multiple timeframes.

Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

With a decisive break above Rs 1189.35 on 20 Aug 2026, Sudeep Pharma has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

Extending its winning streak to three sessions, Sudeep Pharma Ltd touched a fresh all-time high of Rs 1,189.35 on 20 Aug 2026, marking a significant milestone in its recent rally that has outpaced both its sector and the broader market.